함께 비교하는 진짜 ADC · Antibody · CGT 데이터

CGTBiologicstaleMinicirclePhase 1

Follistatin and klotho gene therapy (Follistatin and klotho gene therapy)

Healthy Adults · Healthy Adults

#HealthyAdults#CGT#Phase1#세포유전치료#CAR-T+2

#Grade2and3LateXerostomiaCausedby#CGT#Phase2#세포유전치료#CAR-T+3

AAV2-hAQP1 Concentration 4 (AAV2-hAQP1 Concentration 4)

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Paroti… · Grade 2 and 3 Late Xerostomia Caused by

#Grade2and3LateXerostomiaCausedby#CGT#Phase2#세포유전치료#CAR-T+3

AAV2-hAQP1 Concentration 2 (AAV2-hAQP1 Concentration 2)

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Paroti… · Grade 2 and 3 Late Xerostomia Caused by

ADCBiologicstaleNational Cancer Institute (NCI)Phase 2

Berzosertib (Berzosertib)

HRD Cancer; SCLC · HRD Cancer

#HRDCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleGilead SciencesPhase 2

LG (Labetuzumab Govitecan, Labetuzumab Govitecan (LG))

Metastatic Colorectal Cancer; Colon Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleNantes University HospitalPhase 2

rAAV2/4.hRPE65 (rAAV2/4.hRPE65)

Leber Congenital Amaurosis · Leber Congenital Amaurosis

#LeberCongenitalAmaurosis#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleUniversity of PennsylvaniaPhase 1

rAAV2-CBSB-hRPE65 (rAAV2-CBSB-hRPE65)

Amaurosis of Leber; Retinal Diseases · Amaurosis of Leber

#AmaurosisofLeber#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleRochePhase 1

atezolizumab (Tecentriq, Atezolizumab and Interleukin-12 Gene Therapy)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleThe Methodist Hospital Research…Phase 2

IL-12 gene therapy (IL-12 gene therapy)

Triple Negative Breast Cancer; Anthracycline-refractory TNBC · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

효능 ORR 90%임상시험 1상태 DISCONTINUED

AntibodystaleRocheApproved

tocilizumab [RoActemra/Actemra] (tocilizumab [RoActemra/Actemra])

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2

CGTBiologicstaleReplimune, Inc.Phase 2

RP1, intra-tumoral injection, oncolytic virus (RP1, intra-tumoral injection, oncolytic virus)

Merkel Cell Carcinoma; Basal Cell Carcinoma · Merkel Cell Carcinoma

#MerkelCellCarcinoma#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleEli Lilly and CompanyPhase 1

LY4052031 (LY4052031)

Metastatic Solid Tumor; Recurrent Solid Tumor · Metastatic Solid Tumor

#MetastaticSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

AntibodystaleNovartis PharmaceuticalsPhase 3

Crizanlizumab (Crizanlizumab)

Sickle Cell Disease · Sickle Cell Disease

#SickleCellDisease#Antibody#Phase3#항체#면역항체+2

CGTBiologicstaleHadassah Medical OrganizationPhase 2

HBI 0201-ESO TCRT (HBI 0201-ESO TCRT)

Sarcoma, Synovial; Sarcoma,Soft Tissue · Sarcoma, Synovial

#SarcomaSynovial#CGT#Phase2#세포유전치료#CAR-T+4

AntibodystaleAmgenPhase 2

EGFR inhibitors (panitumumab, panitumumab (EGFR inhibitors))

Recurrence Free Survival · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+3

효능 ORR 19%임상시험 1상태 RECRUITING

CGTBiologicstaleInge Marie SvanePhase 1

ADP-TILIL7 (ADP-TILIL7)

Melanoma Stage III; Melanoma Stage IV · Melanoma Stage III

#MelanomaStageIII#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

autologous anti-gp 100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes (autologous anti-gp 100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes)

Skin Cancer; Melanoma · Skin Cancer

#SkinCancer#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-Thyroglobulin mTCR PBL (Anti-Thyroglobulin mTCR PBL)

Metastatic Thyroid Cancer · Metastatic Thyroid Cancer

#MetastaticThyroidCancer#CGT#Phase2#세포유전치료#CAR-T+2

AntibodystaleAkesoPhase 2

Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine (Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#항체#면역항체+3

AntibodystaleTaipei Tzu Chi Hospital, Buddhi…Approved

Omalizimab (Omalizimab)

Asthma Patients · Asthma Patients

#AsthmaPatients#Antibody#Approved#항체#면역항체+2

ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK002 (NEOK002)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleUniversity of MiamiPhase 2

mTOR inhibitor + Selective estrogen receptor modulator (mTOR inhibitor + Selective estrogen receptor modulator)

Breast Cancer; ER-positive Breast Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4

CGTAAVBiologicstaleBlackfinBio LtdPhase 2

AAV9-CBh-AP4B1 (BFB-101, BFB-101 (AAV9-CBh-AP4B1))

HSP; Hereditary Spastic Paraplegia · HSP

#HSP#CGT#Phase2#세포유전치료#CAR-T+3

AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab)

Advanced HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3

8009갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4684Antibody 2713CGT →Psoriasis →NSCLC 44FDA 승인

108 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 5,423 / 16,063

8429프로그램 44FDA 승인

5,423오늘 방문

16,063누적 방문

피드 Data Tier 차세대 Insight

peripheral blood progenitor cells carrying MDR1 (peripheral blood progenitor cells carrying MDR1)

Breast Neoplasms; Neoplasm Metastasis · Breast Neoplasms

#BreastNeoplasms#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleMinicirclePhase 1

Follistatin and klotho gene therapy (Follistatin and klotho gene therapy)

Healthy Adults · Healthy Adults

#HealthyAdults#CGT#Phase1#세포유전치료#CAR-T+2

#Grade2and3LateXerostomiaCausedby#CGT#Phase2#세포유전치료#CAR-T+3

AAV2-hAQP1 Concentration 4 (AAV2-hAQP1 Concentration 4)

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Paroti… · Grade 2 and 3 Late Xerostomia Caused by

#Grade2and3LateXerostomiaCausedby#CGT#Phase2#세포유전치료#CAR-T+3

AAV2-hAQP1 Concentration 2 (AAV2-hAQP1 Concentration 2)

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Paroti… · Grade 2 and 3 Late Xerostomia Caused by